Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vascular smooth muscle potassium channels comprise several families—primarily voltage-gated potassium channels (Kv), large-conductance calcium–activated potassium channels (BK or KCa), inward rectifier potassium channels (Kir), and ATP-sensitive potassium channels (KATP)—that play essential roles in regulating the excitability, contractility, and tone of arterial smooth muscle. These proteins control the membrane potential by mediating K+ efflux; their activation leads to hyperpolarization, closure of voltage-dependent calcium channels, reduced intracellular calcium influx, relaxation of the vessel wall, and thus vasodilation. Conversely, inhibition causes depolarization and promotes contraction. They integrate multiple physiological signals from pressure changes to vasoactive substances. Dysfunction or altered regulation is implicated in cardiovascular diseases such as hypertension and diabetes. While "vascular smooth muscle potassium channel protein" is not a single molecular entity but rather refers collectively to these various subtypes within arterial myocytes, each subtype has unique regulatory properties that contribute specifically to fine-tuning microvascular function.
Hyperpolarization of membrane potential leading to vasodilation when channels are opened/activated Depolarization and vasoconstriction when channels are blocked/inhibited
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vascular smooth muscle potassium channel protein.